Advances in cardiovascular research. Volume 1 /

Mostrar otras versiones (1)

Secondary Prevention -- Introduction -- Early and DUTCH Trials -- Summary -- Cost effectiveness of ICDs -- Summing up and Future Directions -- Abbreviations -- References -- A Historical View of Advances in the Resuscitation of Patients in Ventricular Fibrillation from the Perspective of Emergency M...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Schmitt, Lukas, König, Timm
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Nova Biomedcial Books, ©2010.
Colección:Advances in Cardiovascular Research.
Temas:
Cardiovascular system > Diseases.
Cardiovascular Diseases > therapy
Cardiovascular Diseases
Appareil cardiovasculaire > Maladies.
HEALTH & FITNESS > Health Care Issues.
MEDICAL > Public Health.
MEDICAL > Health Policy.
HEALTH & FITNESS > Diseases > General.
MEDICAL > Diseases.
MEDICAL > Health Care Delivery.
Cardiovascular system > Diseases
Acceso en línea:Texto completo
Tabla de Contenidos:
  • ADVANCES IN CARDIOVASCULAR RESEARCH, VOLUME 1
  • ADVANCES IN CARDIOVASCULAR RESEARCH, VOLUME 1
  • Contents
  • Preface
  • The Mitral Valve: Development, Structure, Pathology & Tissue Engineering
  • Abstract
  • I. Development of the Mitral Valve Apparatus
  • II. Histological Anatomy of the Mitral Valve
  • III. Surface Topographical and Ultrastructural Anatomy of the Mitral Valve
  • III. I. Surface Topography of the Mitral Valve
  • III. II. Ultrastructure of the Mitral Valve
  • III. II. I. Endocardial endothelium (EE)
  • III. II. II. Valvar interstitial cells (VIC) III. II. III. Extracellular matrix (ECM)
  • III. II. IV. Neural elements
  • IV. Myxomatous Mitral Valve Disease (Canine Model)
  • IV. I. Clinical Features and Natural Disease Progression
  • IV. II. Pathology of Myxomatous Mitral Valve Disease
  • IV. III. Pathogenesis and Pathophysiology of Myxomatous Mitral Valve Disease
  • V. Mitral Valve Regeneration & Tissue Engineering
  • V.I. Cell Sourcing for Mitral Valve Tissue Engineering
  • V. II. Scaffold Development for Mitral Valve Tissue Engineering
  • v. III. Bioreactor Development for Mitral Valve Tissue EngineeringV. IV. Challenges in the Field of Mitral Valve Tissue Engineering
  • References
  • Review of Treatment of Ventricular Fibrillation
  • Abstract
  • Cardiopulmonary Resuscitation
  • Drug Therapy of Ventricular Fibrillation
  • Introduction
  • Amiodarone
  • Sotalol
  • Automated External Defibrillators & Public Access Defibrillation
  • Introduction
  • The Modern AED
  • Public Access Defibrillation (PAD)
  • The Implantable Cardioverter-Defibrillator
  • Introduction
  • Primary Prevention
  • Summary Secondary Prevention
  • Introduction
  • Early and DUTCH Trials
  • Summary
  • Cost effectiveness of ICDs
  • Summing up and Future Directions
  • Abbreviations
  • References
  • A Historical View of Advances in the Resuscitation of Patients in Ventricular Fibrillation from the Perspective of Emergency Medical Services
  • Abstract
  • Introduction
  • Cardiovascular Disease and Sudden Cardiac Death: The Demographics and Survival Rates of Patient in VF
  • Mechanism of Sudden Cardiac Death and Ventricular Fibrillation: The Arrhythmogenicity of Myocardial Ischaemia Establishment of the International Liason Committee on Resuscitation to Develop a Concerted International Approach
  • Conclusion: A Look to the Future
  • References
  • The Ambiguous Role of Epinephrine in Ventricular Fibrillation
  • Abstract
  • Introduction
  • Epinephrine in CPR
  • Epinephrine in the Human Organism
  • Pathophysiology of CA
  • Three-Phase Ventricular Fibrillation Model
  • Adverse Effects of Epinephrine

Ejemplares similares